v3.25.1
Segment
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment

11. Segment

The Company is managed on a consolidated basis with a single reportable segment, chemical manufacturing, which is not an aggregation of individual operating segments. There have been no changes in the basis of segmentation or in the basis of measurement of segment profit or loss since the filing of our 2024 Form 10-K.

Information about reported segment revenue, measures of a segment’s profit or loss, significant segment expenses, and measure of a segment's assets:

 

 

Three Months Ended March 31,

 

 

2025

 

2024

 

 

(In Thousands)

Net sales

 

$143,432

 

$138,204

Less:

 

 

 

 

Cost of sales excluding depreciation, amortization
  and turnaround expense

 

106,990

 

97,917

Depreciation and amortization

 

20,063

 

17,094

Turnaround expense

 

1,995

 

915

    Total cost of sales

 

129,048

 

115,926

Selling, general and administrative

 

 

 

 

Wages and benefits

 

6,219

 

6,143

   Other selling general and administrative

 

3,934

 

4,151

Total selling general and administrative

 

10,153

 

10,294

Interest expense

 

8,064

 

9,729

(Gain) loss on extinguishments of debt

 

—

 

(1,134)

Loss from asset write-down and disposals

 

71

 

1,455

Income tax (benefit) provision

 

(283)

 

603

Other segment items (a)

 

(1,981)

 

(4,292)

Segment net (loss) income

 

(1,640)

 

5,623

 

 

 

 

 

Reconciliation of profit or loss

 

 

 

 

Adjustments and reconciling items

 

—

 

—

Consolidated net (loss) income

 

$(1,640)

 

$5,623

(a) During the first quarter of 2025 and 2024, amount consisted primarily of interest and sublease income.

The measure of our chemical manufacturing segment assets is reported on the condensed consolidated balance sheet as total assets. Expenditures for long-lived chemical manufacturing segment assets are reported on our condensed consolidated statement of cash flows.